A detailed history of Wells Fargo & Company transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,917,821 shares of MRK stock, worth $1.45 Billion. This represents 0.39% of its overall portfolio holdings.

Number of Shares
14,917,821
Previous 15,617,960 4.48%
Holding current value
$1.45 Billion
Previous $1.93 Billion 12.38%
% of portfolio
0.39%
Previous 0.48%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $77.8 Million - $90.3 Million
-700,139 Reduced 4.48%
14,917,821 $1.69 Billion
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $93.9 Million - $101 Million
-758,740 Reduced 4.63%
15,617,960 $1.93 Billion
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $12.9 Million - $15.1 Million
114,181 Added 0.7%
16,376,700 $2.16 Billion
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $15.2 Million - $16.5 Million
-151,738 Reduced 0.92%
16,262,519 $1.77 Billion
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $122 Million - $136 Million
-1,185,625 Reduced 6.74%
16,414,257 $1.69 Billion
Q2 2023

Aug 15, 2023

SELL
$108.61 - $118.38 $29.5 Million - $32.1 Million
-271,419 Reduced 1.52%
17,599,882 $2.03 Billion
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $46.7 Million - $52.1 Million
-453,650 Reduced 2.48%
17,871,301 $1.9 Billion
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $50 Million - $64.1 Million
-572,173 Reduced 3.03%
18,324,951 $2.03 Billion
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $17.5 Million - $19.6 Million
-206,536 Reduced 1.08%
18,897,124 $1.63 Billion
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $77.5 Million - $87.8 Million
-928,242 Reduced 4.63%
19,103,660 $1.74 Billion
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $99.5 Million - $112 Million
1,354,007 Added 7.25%
20,031,902 $1.64 Billion
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $160 Million - $200 Million
-2,212,150 Reduced 10.59%
18,677,895 $1.43 Billion
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $35.8 Million - $39.4 Million
-499,610 Reduced 2.34%
20,890,045 $1.57 Billion
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $67.3 Million - $74.5 Million
-957,686 Reduced 4.29%
21,389,655 $1.66 Billion
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $4.52 Million - $5.33 Million
-65,673 Reduced 0.29%
22,347,341 $1.72 Billion
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $34.6 Million - $38.4 Million
-482,597 Reduced 2.11%
22,413,014 $1.83 Billion
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $47.4 Million - $53.7 Million
-647,926 Reduced 2.75%
22,895,611 $1.9 Billion
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $39.5 Million - $44.9 Million
560,767 Added 2.44%
23,543,537 $1.82 Billion
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $1.46 Billion - $2.02 Billion
22,982,770 New
22,982,770 $1.77 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.